Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia (2020)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/science.aax5863
PubMed Identifier: 32001657
Publication URI: http://europepmc.org/abstract/MED/32001657
Type: Journal Article/Review
Parent Publication: Science
Issue: 6477
ISSN: 0036-8075